NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Canada drops select retaliatory tariffs on U.S. goods, aiming to align with CUSMA exemptions and improve conditions ahead of upcoming continental trade talks.Read More